CROs/Service Providers

PPD names CEO, puts acquisition rumors in question

Monday, September 26, 2011 08:02 AM

PPD has named a new CEO, a move that strikes some in the industry as a little strange in the face of rumors that the publicly traded CRO is close to selling itself to a private equity firm.

More... »

Enzon to cut half of its workforce in 2012

Friday, September 23, 2011 01:14 PM

Enzon Pharmaceuticals, a biotechnology company, said it will cut almost half its workforce in June 2012 to reduce annual operating costs by about $6 million, according to Bloomberg.

More... »

Pacific Biosciences cuts 28% of its workforce

Wednesday, September 21, 2011 01:32 PM

Pacific Biosciences of Menlo Park, CA is laying off 130 employees, or 28% of its total workforce, according to Xconomy.

More... »

Kellman, Y-Prime partner to develop clinical tools

Thursday, September 15, 2011 12:28 PM

Kellman Pharmaceutical Services (KPS), a contract research organization has formed a strategic alliance with Y-Prime, a provider of clinical trial management services and software.

More... »

Spaulding, Frontage partner in clinical development

Tuesday, September 13, 2011 01:37 PM

Spaulding Clinical Research, the US-based provider of clinical pharmacology and cardiac core-laboratory services is extending its reach further east through an alliance with Frontage Laboratories, according to PharmaTimes.

More... »

Icon CEO Peter Gray to step down after nine years; CFO Ciaran Murray takes the helm as of Oct. 1

Monday, September 12, 2011 08:02 AM

Peter Gray, CEO of Icon since 2002, will step down as of Oct. 1. The announcement, which came last week, surprised many in the industry.  Icon’s board has appointed Ciaran Murray, who has been Icon’s CFO for the last six years, to succeed Gray as CEO.

More... »

MakroCare partners with LSK in Asian, US markets

Tuesday, September 6, 2011 02:28 PM

A new alliance between MakroCare and LSK Global Pharmaceutical Services offers a single entry point to a range of drug development and commercialization services in key Asian markets as well as the US, according to PharmaTimes.

More... »

Icon and Bristol-Myers Squibb build on strategic partnership, extending it to early-phase work

Monday, September 5, 2011 08:00 AM

Icon and Bristol-Myers Squibb (BMS) have inked a preferred-provider agreement for early-phase development. This constitutes the CRO’s second sizable agreement with BMS; in June 2010, the two formed a strategic partnership, with Icon focused on providing global support for the drug developer’s clinical development pipeline.

More... »

As big CROs keep getting bigger, smaller CROs Estern, Harrison are expanding globally

Monday, August 29, 2011 08:02 AM

As medium-sized and large CROs continue their quest to get bigger and get acquired, smaller CROs are on the march around the globe, expanding as best they can to attract contracts from smaller pharmaceutical companies and biotechs seeking something approximating worldwide reach.

More... »

PharMerica adopts poison pill to prevent takeover

Friday, August 26, 2011 01:25 PM

U.S. pharmacy services provider PharMerica adopted a poison pill to prevent hostile takeovers, two days after Omnicare went public with its bid to acquire the company for $441 million, according to Reuters.

More... »